Penrose Cancer Center

Penrose-St. Frances Health Services

2222 N Nevada Ave
Colorado Springs, Colorado 80907

38.8655367, -104.821745

Latitude: 38.8655367, Longitude: -104.821745

Penrose Cancer Center

Penrose-St. Frances Health Services

Conditions We Treat

World-Class Cancer Care in Colorado Springs

To get the very best cancer care, you don't have to travel very far. Strengthened by the Centura Health network, Colorado and Kansas' largest system of hospitals working together to treat more cancer patients, the Penrose Cancer Center brings world-class cancer technology and physicians right to southern Colorado's residents. We have been providing quality cancer care to adult patients since 1939, are one of the best-known, longest-standing community cancer programs in the western United States and have been a pioneer in radiation oncology for more than 70 years.

We offer a full range of clinical trials, psychosocial support services and nurse navigation and pride ourselves on a multidisciplinary approach to care: uniting surgeons, medical and radiation oncologists as well as oncology certified nurses and ancillary staff to deliver the best possible outcome for patients. We are also part of the Centura Health Cancer Network, a comprehensive statewide cancer network that brings together the best and brightest minds in cancer care, armed with leading edge technologies and capabilities that offer a complete array of services, connecting patients with all types of cancers and blood disorders to the most advanced care available in Colorado.  

  • Brain Cancer

    There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly.

    Learn more about Brain Cancer.

    Treatment options include:

    • Surgery
    • Radiation therapy (including Cyberknife®)
    • Chemotherapy
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact type and location of the tumor, the stage of the cancer, and the person's age and general health.

    Did you know?

    • Compared to open brain surgery, our Cyberknife is a very safe, precise, and reliable treatment option with minimal to no side effects or recovery time.
  • Breast Cancer

    Breast Cancer is a disease in which malignant cells form in the tissues of the breast. The most common type of breast cancer is ductal carcinoma, which begins in the cells of the ducts. Cancer that begins in the lobes or lobules is called lobular carcinoma and is more often found in both breasts than are other types of breast cancer. Inflammatory breast cancer is an uncommon type of breast cancer in which the breast is warm, red, and swollen. Breast cancer may be invasive or noninvasive. Invasive means it has spread from the milk duct or lobule to other tissues in the breast. Noninvasive means it has not yet invaded other breast tissue. Noninvasive breast cancer is called "in situ." 

    Learn more about Breast Cancer.

    Treatment options include:

    • Surgery
    • Lumpectomy
    • Lymph node dissection
    • Partial mastectomy
    • Full mastectomy
    • Breast reconstruction
    • Biopsy
    • Radiation therapy (including Cyberknife®)
    • Chemotherapy
    • Hormone therapy
    • Targeted therapy
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact type and location of the tumor, the stage of the cancer, and the person's age and general health.

    Contact our Breast Nurse navigator.

    Phone: 719-776-5955

    Did you know?

    • The Breast Oncology program is Penrose Cancer Center's oldest and busiest multidisciplinary program. A team comprised of surgeons, radiation oncologists, medical oncologists, genetics professionals, care navigators, clinical trial specialists, and other support staff meets on a weekly basis to discuss management of new breast cancer or high risk breast referrals.
    • In the first quarter of 2012, here is the average amount of time it took for breast cancer patients to receive treatment:
      • Time from a screening Mammogram to initial appointment  - 11 days
      • Time from initial diagnosis to a biopsy - 7 days
      • Time from a biopsy to a full lab report  - 3 days
      • Time from full diagnosis to beginning treatment - 17 days
    • We are proud to be accredited by the National Accreditation Program for Breast Centers. Receiving care at a NAPBC-accredited center ensures that you will have access to quality, comprehensive care close to home, a multidisciplinary team approach, information about ongoing clinical trials, and information about new treatment options.
  • Colon & Rectal Cancer

    Colon, or colorectal, cancer is cancer that starts in the large intestine (colon) or the rectum (end of the colon). According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer-related deaths in the United States. However, early diagnosis can often lead to a complete cure.

    Almost all colon cancer starts in glands in the lining of the colon and rectum. When doctors talk about colorectal cancer, this is usually what they are talking about. There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.

    Learn more about colon and rectal cancer

    Treatment options include:

    • Surgery
    • Radiation therapy (including Cyberknife®)
    • Chemotherapy
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact type and location of the tumor, the stage of the cancer, and the person's age and general health.

    Contact our Gastrointestinal Nurse navigator.

    Phone:  719-776-5954

    Did you know?

    • In the past 10 years, more than 2,000 gastric and 1,000 colon procedures have been performed by our team of highly-trained and specialized surgeons.
    • Our services include a full array of minimally-invasive (laparoscopic) surgery techniques designed to improve patient outcomes and decrease hospital stays.
    • On average, it takes 38 days for our gastrointestinal cancer patients to go through surgery and begin chemotherapy. The national range is 30-41 days.
  • Head & Neck Cancer

    Head & Neck Cancer is a type of cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx. At Penrose Cancer Center, our goals of treatment, besides curing, include retaining the patient's ability to speak, eat, smell and breathe in an acceptable manner. Achieving these goals requires the coordination of care between surgeons, radiation oncologists and medical oncologists, as well as support disciplines such as pathology, diagnostic radiology, dentistry, voice and swallowing therapists and care navigators.

    Learn more about Learn more about Head & Neck Cancer.

    Treatment options include:

    • Surgery (including minimally-invasive techniques)
    • Radiation therapy (including Cyberknife®)
    • Chemotherapy
    • Targeted therapy
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact location of the tumor, the stage of the cancer, and the person's age and general health.

    Did you know?

    • In our head and neck cancer patients we have a goal of limiting weight loss to 10% and in 2011 the average weight loss of our patients during therapy was 5.5%
    • Dr. Joel Ernster & Dr. Alan Monroe have authored four papers  on head and neck cancer in peer reviewed journals in the past five years
    • Our staff includes:
      • Some of the busiest and most experienced thyroid and parathyroid surgeons in the western United States
      • Recognized HPV (human papilloma virus)-associated head and neck malignancies
      • Outstanding surgeons and specialists trained in the complex treatment of Cyberknife® for selected cases of skull base malignancies
  • Leukemia & Lymphoma

    Hematologic cancers, (cancers of the blood, bone marrow, and lymph nodes) include leukemia, lymphoma, and myeloma. Every year, more than 100,000 cases of blood, bone marrow, and lymph node cancers are diagnosed in the United States, and more than 50,000 people die from these cancers. Among children and teens less than 20 years old, leukemia is the most common cancer and the leading cause of cancer death. Leukemia is a cancer of the bone marrow and blood and lymphoma is a general term for cancers that start in the lymph system.

    Learn more about Hematologic Cancers.

    Treatment options include:

    • Radiation therapy
    • Chemotherapy
    • Targeted therapy
    • Surgery (less common) 
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact type of cancer, the stage of the cancer, and the person's age and general health.

    Contact our hematology nurse navigator.

    Phone: 719-776-6183

    Did you know?

    • We provide diagnosis and management of all blood disorders, specializing in coagulation problems, anemias, white cell and platelet problems, and other bone marrow disorders.
  • Prostate Cancer

    Prostate cancer is a type of cancer that forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). Prostate cancer usually occurs in older men and is typically a very slow growing tumor, often causing no symptoms until it is in an advanced stage. Most men with prostate cancer die of other causes -- many without ever realizing that they have the disease. But once prostate cancer begins to grow more rapidly or spreads outside the prostate, it is very dangerous.

    Learn more about prostate cancer.

    Treatment options include:

    • Surgery
    • Radiation therapy (including Cyberknife® and brachytherapy)
    • Chemotherapy
    • Hormone therapy
    • Targeted therapy
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact type and location of the tumor, the stage of the cancer, and the person's age and general health.

    Contact our prostate nurse navigator.

    Phone: 719-776-5281

    Did you know?

    • Patients treated here for prostate cancer in 2003, the last year for which complete 5-year survival data are available, achieved 93% 5-year survival. This compares favorably with data from university and teaching hospitals (90%) and a set of comparable Catholic community hospitals (86%).
    • Penrose-St. Francis urologic surgeons are among the most experienced in the state, with over 200 robotic prostatectomies performed annually.
    • Average duration of hospital stay for our prostate cancer patients has progressively improved to an average of 1 day, with an average operating time of approximately 3 hours.
    • We have the state's largest experience with HDR (high dose rate brachytherapy). HDR offers focused high dose internal treatments that can be completed as an outpatient with minimal complications.
  • Skin Cancer

    Skin cancer — the abnormal growth of skin cells — most often develops on skin exposed to the sun but can also occur on areas of your skin not ordinarily exposed to sunlight. Skin cancer is the most common of all cancers. It accounts for nearly half of all cancers in the United States. There are three major types of skin cancer — basal cell carcinoma, squamous cell carcinoma and melanoma.

    Learn more about skin cancer.

    Treatment options include:

    • Surgery
    • Radiation therapy
    • Chemotherapy
    • Or a combination of treatments

    The treatment plan for an individual patient depends on a number of factors, including the exact type of cancer, size, depth, location and the stage of the cancer, and the person's age and general health.